RJFSA
ZYME icon

Raymond James Financial Services Advisors’s Zymeworks ZYME Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$697K Sell
55,514
-1,867
-3% -$20.3K ﹤0.01% 2400
2024
Q2 		$488K Sell
57,381
-604
-1% -$5.38K ﹤0.01% 2553
2024
Q1 		$610K Sell
57,985
-2,013
-3% -$22.4K ﹤0.01% 2372
2023
Q4 		$623K Sell
59,998
-203
-0.3% -$1.62K ﹤0.01% 2271
2023
Q3 		$382K Sell
60,201
-1,765
-3% -$13K ﹤0.01% 2489
2023
Q2 		$535K Buy
61,966
+4,139
+7% +$37.1K ﹤0.01% 2311
2023
Q1 		$523K Buy
57,827
+1,379
+2% +$12K ﹤0.01% 2309
2022
Q4 		$444K Sell
56,448
-16,076
-22% -$113K ﹤0.01% 2334
2022
Q3 		$446K Buy
72,524
+2,281
+3% +$13.8K ﹤0.01% 2315
2022
Q2 		$372K Sell
70,243
-1,724
-2% -$10.4K ﹤0.01% 2450
2022
Q1 		$471K Buy
71,967
+7,868
+12% +$70.1K ﹤0.01% 2418
2021
Q4 		$1.05M Sell
64,099
-11,466
-15% -$239K ﹤0.01% 1957
2021
Q3 		$2.19M Sell
75,565
-458
-0.6% -$15.2K ﹤0.01% 1436
2021
Q2 		$2.64M Buy
76,023
+1,173
+2% +$37.2K 0.01% 1327
2021
Q1 		$2.36M Buy
74,850
+10,423
+16% +$424K 0.01% 1295
2020
Q4 		$3.04M Sell
64,427
-965
-1% -$44.8K 0.01% 1065
2020
Q3 		$3.05M Buy
65,392
+21,594
+49% +$741K 0.01% 973
2020
Q2 		$1.58M Buy
43,798
+1,421
+3% +$52.3K 0.01% 1220
2020
Q1 		$1.5M Sell
42,377
-8,307
-16% -$340K 0.01% 1026
2019
Q4 		$2.3M Buy
50,684
+21,730
+75% +$790K 0.01% 1099
2019
Q3 		$718K Buy
+28,954
New +$725K ﹤0.01% 1671

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Raymond James Financial Services Advisors's ZYME Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Zymeworks (ZYME) stake by 3.3% in Q3 2024, selling an estimated $20.3K and leaving 55,514 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Raymond James Financial Services Advisors first reported a position in ZYME in Q3 2019 and has held it in 21 quarters since. The position peaked at $3.05M in Q3 2020. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.

  • Raymond James Financial Services Advisors held 55,514 shares of Zymeworks worth $697K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 1,867 Zymeworks shares in Q3 2024, an estimated $20.3K.
  • Zymeworks made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2400 holding.
  • Raymond James Financial Services Advisors first reported a position in Zymeworks in Q3 2019 and has held it in 21 quarters since.
  • Raymond James Financial Services Advisors's Zymeworks position peaked at $3.05M in Q3 2020.
  • 163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.